Abstract
Cardiac risk stratification (HCT-CI) for patients with multiple myeloma (MM) planning autologous hematopoietic stem cell transplant (ASCT) may not capture cardiovascular risk. In addition to more prevalent cardiovascular comorbidities, MM patients are also at risk for concurrent light chain cardiac
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
